Source: ERJ Open Res, 6 (3) 00351-2019; 10.1183/23120541.00351-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Suzanne Boer, Persijn J. Honkoop, Rik J.B. Loijmans, Jiska B. Snoeck-Stroband, Willem J.J. Assendelft, Tjard R.J. Schermer, Jacob K. Sont. Personalised exhaled nitric oxygen fraction (F_ENO)-driven asthma management in primary care: a F_ENO subgroup analysis of the ACCURATE trial. ERJ Open Res, 6 (3) 00351-2019; 10.1183/23120541.00351-2019

Member's Comments

No comment yet.

Related content which might interest you: The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Opinions towards the implementation of spirometry and exhaled nitric oxide testing in children under investigation for asthma in primary care Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018 Meta analysis of asthma exacerbation rates in adult and pediatric asthmatics managed using fractional exhaled nitric oxide versus standard clinical parameters alone Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma? Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019 Year: 2020 Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance? Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma Source: Eur Respir J 2007; 30: 545-548 Year: 2007 Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma? Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes Year: 2019 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 High occurrence of elevated exhaled nitric oxide (eNO) in non-atopic patients attending a specialist respiratory clinic Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003 Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma Source: Eur Respir J 2010; 35: 1200-1202 Year: 2010 Asthma exacerbations and exhaled nitric oxide: a randomised controlled trial Source: Eur Respir J 2006; 28: Suppl. 50, 572s Year: 2006 Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010